Cargando…
Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay
Interferon gamma (IFN-γ), a signal proinflammatory cytokine secreted by immune cell, and plays a critical role in the pathogenesis and progression of many diseases. It has been regarded as an important marker for determination of disease-specific immune responses. Therefore, it is urgent to develop...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850876/ https://www.ncbi.nlm.nih.gov/pubmed/29563896 http://dx.doi.org/10.3389/fmicb.2018.00261 |
_version_ | 1783306299352547328 |
---|---|
author | Yang, Hang Zhong, Yanfang Wang, Juncheng Zhang, Qinghong Li, Xiulan Ling, Sumei Wang, Shihua Wang, Rongzhi |
author_facet | Yang, Hang Zhong, Yanfang Wang, Juncheng Zhang, Qinghong Li, Xiulan Ling, Sumei Wang, Shihua Wang, Rongzhi |
author_sort | Yang, Hang |
collection | PubMed |
description | Interferon gamma (IFN-γ), a signal proinflammatory cytokine secreted by immune cell, and plays a critical role in the pathogenesis and progression of many diseases. It has been regarded as an important marker for determination of disease-specific immune responses. Therefore, it is urgent to develop a feasible and accurate method to detect IFN-γ in clinic real blood samples. Until now, the immunoassay based on singe chain variable fragment (scFv) antibody for human IFN-γ is still not reported. In the present study, an scFv antibody named scFv-A8 with high specificity was obtained by phage display and biopanning, with the affinity 2.6 × 10(9) L/mol. Maltose binding protein (MBP) was used to improve the solubility of scFv by inserting an linker DNA between scFv and MBP tag, and the resulted fusion protein (MBP-LK-scFv) has high solubility and antigen biding activity. The expressed and purified MBP-LK-scFv antibody was used to develop the indirect competitive enzyme-linked immunosorbent assay (ELISA) (ic-ELISA) for detection of human IFN-γ, and the result indicated that the linear range to detect IFN-γ was 6–60 pg/mL with IC(50) of 25 pg/mL. The limit of detection was 2 pg/mL (1.3 fm), and the average recovery was 85.05%, further demonstrating that the detection method based on scFv has higher recovery and accuracy. Hence, the developed ic-ELISA can be used to detect IFN-γ in real samples, and it may be further provided a scientific basis for disease diagnosis. |
format | Online Article Text |
id | pubmed-5850876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58508762018-03-21 Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay Yang, Hang Zhong, Yanfang Wang, Juncheng Zhang, Qinghong Li, Xiulan Ling, Sumei Wang, Shihua Wang, Rongzhi Front Microbiol Microbiology Interferon gamma (IFN-γ), a signal proinflammatory cytokine secreted by immune cell, and plays a critical role in the pathogenesis and progression of many diseases. It has been regarded as an important marker for determination of disease-specific immune responses. Therefore, it is urgent to develop a feasible and accurate method to detect IFN-γ in clinic real blood samples. Until now, the immunoassay based on singe chain variable fragment (scFv) antibody for human IFN-γ is still not reported. In the present study, an scFv antibody named scFv-A8 with high specificity was obtained by phage display and biopanning, with the affinity 2.6 × 10(9) L/mol. Maltose binding protein (MBP) was used to improve the solubility of scFv by inserting an linker DNA between scFv and MBP tag, and the resulted fusion protein (MBP-LK-scFv) has high solubility and antigen biding activity. The expressed and purified MBP-LK-scFv antibody was used to develop the indirect competitive enzyme-linked immunosorbent assay (ELISA) (ic-ELISA) for detection of human IFN-γ, and the result indicated that the linear range to detect IFN-γ was 6–60 pg/mL with IC(50) of 25 pg/mL. The limit of detection was 2 pg/mL (1.3 fm), and the average recovery was 85.05%, further demonstrating that the detection method based on scFv has higher recovery and accuracy. Hence, the developed ic-ELISA can be used to detect IFN-γ in real samples, and it may be further provided a scientific basis for disease diagnosis. Frontiers Media S.A. 2018-03-07 /pmc/articles/PMC5850876/ /pubmed/29563896 http://dx.doi.org/10.3389/fmicb.2018.00261 Text en Copyright © 2018 Yang, Zhong, Wang, Zhang, Li, Ling, Wang and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Yang, Hang Zhong, Yanfang Wang, Juncheng Zhang, Qinghong Li, Xiulan Ling, Sumei Wang, Shihua Wang, Rongzhi Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay |
title | Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay |
title_full | Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay |
title_fullStr | Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay |
title_full_unstemmed | Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay |
title_short | Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay |
title_sort | screening of a scfv antibody with high affinity for application in human ifn-γ immunoassay |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850876/ https://www.ncbi.nlm.nih.gov/pubmed/29563896 http://dx.doi.org/10.3389/fmicb.2018.00261 |
work_keys_str_mv | AT yanghang screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay AT zhongyanfang screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay AT wangjuncheng screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay AT zhangqinghong screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay AT lixiulan screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay AT lingsumei screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay AT wangshihua screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay AT wangrongzhi screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay |